移植后巨细胞病毒感染的诊断方法及其优劣性比较
被引量：1
摘要
巨细胞病毒(CMV)感染是移植后患者死亡的最重要的感染性原因。敏感性及特异性强的CMV检测方法在CMV感染的防治方面可起到关键作用。本文对目前移植后CMV感染的诊断方法血清学方法、培养法、抗原血症法、聚合酶链反应、核糖核酸序列扩增法和核酸杂交法等作一综述。
出处
《国外医学（输血及血液学分册）》
2004年第3期257-260,共4页
Foreign Medical Sciences(Section of Blood Transfusion and Heanatology)
参考文献26
-
1Poirier T,Milpied N, Cantarovich D, et al. Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients. J Clin Microbiol, 2000, 38(9):3143-3149.
-
2Boriskin YS,Fuller K,Powles RL,et al. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. J Clin Virol, 2002, 24(1):13-23.
-
3Caliendo AM, St George K, Kao SY, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol, 2000, 38(6):2122-212
-
4Piiparinen H,Hockerstedt K,Lappalainen M,et al. Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J Clin Microbiol, 2002, 40(8):2945-2952.
-
5Razonable RR,Brown MJ,Espy A, et al. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol, 2001, 39(12):4472-4476.
-
6Pang XL, Chui L, Fenton J, et al. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transpl
-
7Yun Z, Lewensohn-Fuchs I, Ljungman P, et al. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J Virol Methods, 2003, 110(1):73-79.
-
8Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood, 2003, 101(2):407-414.
-
9Witt DJ, Kemper M, Stead A, et al. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection. J Clin Microbiol, 2000, 38(11):3994-3999.
-
10Blok MJ, Lautenschlager I, Goossens VJ, et al. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification. J Clin Microbi
同被引文献9
-
1Ljungman P,Einsele H.Viral infections.In:Atkinson K,Champlin R,Ritz J,eds.Clinical bone marrow and blood stem cell transplantation.3rd ed.Cambridge:Cambridge U niversity Press,2004.1180-1206.
-
2Nesbitt SE,Cook L,Jerome KR.Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood.J Clin Microbiol,2004,42:12961297.
-
3Cortez KJ,Fischer SH,Fahle GA,et al.Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients.J Infect Dis,2003,188:967-972.
-
4Schvoerer E,Henriot S,Zachary P,et al.Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.J Med Virol,2005,76:76-81.
-
5Li H,Dummer JS,Estes WR,et al.Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients.J Clin Microbiol,2003,41:187-191.
-
6Fraser GA,Walker Ⅱ.Canadian Blood and Marrow Transplant Group.Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada:a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.Biol Blood Marrow Transplant,2004,10:287-297.
-
7Mori T,Okamoto S,Watanabe R,et al.Dose adjusted preemptive therapy for cytomegalovirus disease based on realtime polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant,2002,29:777-782.
-
8陈以宽,朱仕钦.人巨细胞病毒致病的进展[J].中华传染病杂志,1999,17(3):210-212. 被引量：12
-
9董陆佳,李欲航,秦茂权,余志勇,胡亮钉,徐晨,宁红梅,贾蜀琼,卢淑鹃.造血干细胞移植术后患者巨细胞病毒感染发生率及临床转归[J].解放军医学杂志,2002,27(7):601-603. 被引量：5
引证文献1
-
1张晓艳,李建勇,吴汉新,戎国栋,钱思轩,张卫,黄佩珺,洪鸣,张闰.造血干细胞移植后对人巨细胞病毒感染病毒载量的检测[J].中华传染病杂志,2006,24(6):401-405. 被引量：6
二级引证文献6
-
1谢正德,秦茂权,周翾,王燕,闫静,刘春艳,申昆玲.儿童造血干细胞移植患者的人巨细胞病毒感染[J].中华儿科杂志,2009,47(4):311-313.
-
2陈育红,赵晓甦,刘开彦,许兰平,刘代红,陈欢,张晓辉,韩伟,王昱,赵婷,赵晓涛,黄晓军.造血干细胞移植后患者血浆巨细胞病毒DNA拷贝数与巨细胞病毒病的关系[J].中华医学杂志,2009,89(22):1540-1543. 被引量：6
-
3黄金菊,陆晓茜,闫晨华,赵晓甦,许兰平,黄晓军,刘代红.亲属单倍型与同胞全相合HSCT后巨细胞病毒感染临床特点的比较[J].中华器官移植杂志,2013,34(2):87-91. 被引量：13
-
4金欣,佟利威,许晓跃,吴海涵,袁方,姜雪丹,李占甲,于农.异基因造血干细胞移植后巨细胞病毒感染监测的临床价值[J].分子诊断与治疗杂志,2014,6(2):79-82. 被引量：1
-
5刘川,邹叶青,石庆芝.造血干细胞移植中人巨细胞病毒检测:荧光定量聚合酶链反应的早期诊断价值[J].中国组织工程研究,2014,18(28):4563-4567. 被引量：2
-
6熊世娟,张庆,高文慧.1例肾移植术后肺部感染患者的药学监护[J].医药导报,2015,34(3):413-415. 被引量：1
-
1谭琪佳,王丽.肾移植患者巨细胞病毒感染的实验室诊断[J].医学检验与临床,2007,19(3):111-111. 被引量：1
-
2毛学政,施凯.人巨细胞病毒抗原血症[J].国外医学（微生物学分册）,1993,16(5):196-199.
-
3病毒传染病[J].国外科技资料目录（医药卫生）,2001(7):42-44.
-
4金子政时,谭季春,周吉海.先天性巨细胞病毒感染与抗原血症[J].日本医学介绍,2004,25(12):560-561.
-
5谌贻璞.乙型肝炎病毒相关肾炎[J].西藏医药,2006,27(1):29-30.
-
6董莉,李军,刘婷,陈念,黄祖瑚.乙型肝炎病毒基因分型与临床的相关性探讨[J].中国血液流变学杂志,2006,16(2):237-239. 被引量：4
-
7病毒传染病[J].国外科技资料目录（医药卫生）,1997(6):31-31.
-
8国外医学信息[J].中华医学信息导报,1997,0(5):21-23.
-
9崔京涛,倪安平,吴叶丽,孔令君,严文娟,李倩,窦亚玲,陈兰兰.自身免疫病和非自身免疫病患者巨细胞病毒抗原血症检测及抗病毒治疗后复检观察[J].中华医学杂志,2012,92(34):2426-2429. 被引量：6
-
10HIV-1感染各阶段P24抗原血症,P24抗体血症及中和抗体的相互关系[J].传染病信息,1995,8(1):7-8.
